- Home
- KYMR vs DAN Comparison
KYMR vs DAN Comparison
Compare KYMR & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- DAN
- Stock Information
- Founded
- KYMR 2015
- DAN 1904
- Country
- KYMR United States
- DAN United States
- Employees
- KYMR N/A
- DAN N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- DAN Auto Parts:O.E.M.
- Sector
- KYMR Health Care
- DAN Consumer Discretionary
- Exchange
- KYMR Nasdaq
- DAN Nasdaq
- Market Cap
- KYMR 3.1B
- DAN 2.5B
- IPO Year
- KYMR 2020
- DAN N/A
- Fundamental
- Price
- KYMR $44.91
- DAN $16.81
- Analyst Decision
- KYMR Strong Buy
- DAN Buy
- Analyst Count
- KYMR 16
- DAN 7
- Target Price
- KYMR $58.94
- DAN $20.17
- AVG Volume (30 Days)
- KYMR 875.7K
- DAN 2.6M
- Earning Date
- KYMR 08-06-2025
- DAN 07-30-2025
- Dividend Yield
- KYMR N/A
- DAN 2.38%
- EPS Growth
- KYMR N/A
- DAN N/A
- EPS
- KYMR N/A
- DAN N/A
- Revenue
- KYMR $58,885,000.00
- DAN $9,901,000,000.00
- Revenue This Year
- KYMR $58.26
- DAN N/A
- Revenue Next Year
- KYMR N/A
- DAN N/A
- P/E Ratio
- KYMR N/A
- DAN N/A
- Revenue Growth
- KYMR N/A
- DAN N/A
- 52 Week Low
- KYMR $19.45
- DAN $7.58
- 52 Week High
- KYMR $53.27
- DAN $18.05
- Technical
- Relative Strength Index (RSI)
- KYMR 56.82
- DAN 51.96
- Support Level
- KYMR $43.56
- DAN $17.03
- Resistance Level
- KYMR $45.83
- DAN $17.61
- Average True Range (ATR)
- KYMR 1.77
- DAN 0.46
- MACD
- KYMR -0.49
- DAN -0.10
- Stochastic Oscillator
- KYMR 51.65
- DAN 37.93
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.